Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Scaffolds | 4 | 2022 | 184 | 2.580 |
Why?
|
| Tissue Engineering | 5 | 2022 | 363 | 2.330 |
Why?
|
| Fibroblasts | 3 | 2020 | 836 | 1.160 |
Why?
|
| Bioreactors | 3 | 2020 | 45 | 0.960 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2020 | 115 | 0.930 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2022 | 98 | 0.790 |
Why?
|
| Polyethylene Glycols | 3 | 2022 | 575 | 0.760 |
Why?
|
| Biocompatible Materials | 2 | 2020 | 379 | 0.700 |
Why?
|
| Frailty | 1 | 2022 | 116 | 0.700 |
Why?
|
| Biodegradable Plastics | 1 | 2019 | 4 | 0.700 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 233 | 0.630 |
Why?
|
| Surgeons | 1 | 2021 | 242 | 0.610 |
Why?
|
| Lower Extremity | 4 | 2022 | 334 | 0.600 |
Why?
|
| Materials Testing | 1 | 2019 | 360 | 0.600 |
Why?
|
| Porosity | 3 | 2022 | 93 | 0.560 |
Why?
|
| Polyglycolic Acid | 3 | 2020 | 44 | 0.550 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2020 | 236 | 0.520 |
Why?
|
| Arteries | 2 | 2014 | 250 | 0.450 |
Why?
|
| Aorta, Abdominal | 1 | 2011 | 40 | 0.400 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 46 | 0.380 |
Why?
|
| Veterans | 1 | 2021 | 1214 | 0.380 |
Why?
|
| Extracellular Matrix | 3 | 2022 | 444 | 0.380 |
Why?
|
| Stress, Mechanical | 3 | 2020 | 441 | 0.360 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2011 | 181 | 0.340 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 455 | 0.330 |
Why?
|
| Risk Assessment | 3 | 2022 | 3041 | 0.320 |
Why?
|
| Postoperative Complications | 3 | 2022 | 2230 | 0.290 |
Why?
|
| Risk Factors | 4 | 2022 | 8950 | 0.250 |
Why?
|
| Pressure | 3 | 2020 | 225 | 0.220 |
Why?
|
| Frail Elderly | 1 | 2022 | 105 | 0.200 |
Why?
|
| Retrospective Studies | 3 | 2022 | 12922 | 0.190 |
Why?
|
| Biomimetics | 1 | 2020 | 38 | 0.180 |
Why?
|
| Tensile Strength | 1 | 2020 | 105 | 0.180 |
Why?
|
| Elastic Modulus | 1 | 2020 | 118 | 0.180 |
Why?
|
| Cross-Linking Reagents | 1 | 2020 | 184 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2022 | 9311 | 0.170 |
Why?
|
| Collagen | 1 | 2020 | 432 | 0.160 |
Why?
|
| Humans | 10 | 2022 | 118066 | 0.150 |
Why?
|
| Extremities | 1 | 2017 | 112 | 0.140 |
Why?
|
| Pain | 1 | 2021 | 735 | 0.130 |
Why?
|
| Skin | 1 | 2020 | 658 | 0.130 |
Why?
|
| Shear Strength | 1 | 2014 | 55 | 0.120 |
Why?
|
| Saphenous Vein | 1 | 2014 | 32 | 0.120 |
Why?
|
| Receptor, EphB4 | 1 | 2014 | 29 | 0.120 |
Why?
|
| Ischemia | 1 | 2017 | 370 | 0.120 |
Why?
|
| Cell Line | 1 | 2019 | 2688 | 0.110 |
Why?
|
| Length of Stay | 1 | 2017 | 1027 | 0.110 |
Why?
|
| Hypertonic Solutions | 1 | 2011 | 8 | 0.100 |
Why?
|
| Rats, Nude | 1 | 2011 | 27 | 0.100 |
Why?
|
| Hydrostatic Pressure | 1 | 2011 | 18 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2017 | 630 | 0.100 |
Why?
|
| Detergents | 1 | 2011 | 44 | 0.100 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 79 | 0.100 |
Why?
|
| Vascular Patency | 1 | 2011 | 98 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 138 | 0.100 |
Why?
|
| Perfusion | 1 | 2011 | 152 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2011 | 120 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 133 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2011 | 134 | 0.090 |
Why?
|
| Sirolimus | 1 | 2011 | 195 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2011 | 184 | 0.090 |
Why?
|
| Endothelial Cells | 2 | 2014 | 717 | 0.090 |
Why?
|
| Blood Coagulation | 1 | 2011 | 202 | 0.090 |
Why?
|
| Biomechanical Phenomena | 1 | 2011 | 684 | 0.080 |
Why?
|
| Swine | 1 | 2011 | 719 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2011 | 714 | 0.080 |
Why?
|
| Stem Cells | 1 | 2011 | 555 | 0.070 |
Why?
|
| Aged | 2 | 2022 | 19557 | 0.070 |
Why?
|
| Time Factors | 2 | 2017 | 6362 | 0.070 |
Why?
|
| United States | 1 | 2021 | 12477 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2254 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2011 | 4042 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 5329 | 0.060 |
Why?
|
| Blood Circulation | 1 | 2002 | 36 | 0.060 |
Why?
|
| Models, Cardiovascular | 1 | 2002 | 179 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2002 | 356 | 0.050 |
Why?
|
| Animals | 2 | 2011 | 33107 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2011 | 4677 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2014 | 13 | 0.030 |
Why?
|
| Hemorheology | 1 | 2014 | 20 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 409 | 0.030 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 273 | 0.030 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 378 | 0.020 |
Why?
|
| Female | 2 | 2017 | 61147 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1698 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 2453 | 0.020 |
Why?
|
| Rheology | 1 | 2002 | 86 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 1002 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 31230 | 0.010 |
Why?
|
| Male | 1 | 2017 | 57376 | 0.010 |
Why?
|